CervoMed Inc. (CRVO) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of CervoMed Inc. and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CRVO

CervoMed Inc.

$30M

$3.20HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT

MDXH

MDxHealth S.A.

$31M

$0.60HealthcareDelayed quote: Oct 6, 2026, 11:47 AM EDT

Total return — CRVO vs MDXH

growth of $100 · dividends reinvested · last 5y

CRVO -90.4% (-37.5%/yr)MDXH -95.0% (-45.1%/yr)CRVO compounded faster over this window

CRVO MDXH

CRVO vs MDXH: by the numbers

•MDXH is the larger company ($31M vs $30M market cap).
•Both run net losses; MDXH's is the smaller (-31.07% vs -9408.76% net margin).

Metrics side by side

Valuation

Metric	CRVO	MDXH
P/S ratio	91.85	N/A
P/B ratio	1.29	N/A

Profitability

Metric	CRVO	MDXH
Gross margin	0.00%	59.74%
Operating margin	0.00%	-14.28%
Net margin	-9408.76%	-31.07%
ROE	-132.18%	N/A
ROIC	-135.73%	-15.35%

Growth (annualized)

Metric	CRVO	MDXH
Revenue CAGR (5Y)	N/A	42.35%
Total return CAGR (5Y)	-38.25%	N/A

Go deeper

Full CRVO analysis Full MDXH analysis Interactive comparison tool

Dig into the metrics

CervoMed ROE MDxHealth ROE CervoMed operating margin MDxHealth operating margin CervoMed revenue growth MDxHealth revenue growth CervoMed free cash flow MDxHealth free cash flow

CervoMed & MDxHealth appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.